Jeroen Sijtsma
Overview
Explore the profile of Jeroen Sijtsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Plas J, Kuiper V, Bagchus W, Bodding M, Yalkinoglu O, Tappert A, et al.
Lancet Infect Dis
. 2023 Jul;
23(10):1164-1174.
PMID: 37414066
Background: Cabamiquine is a novel antimalarial that inhibits Plasmodium falciparum translation elongation factor 2. We investigated the causal chemoprophylactic activity and dose-exposure-response relationship of single oral doses of cabamiquine following...
2.
Wieten L, van der Zee R, Goedemans R, Sijtsma J, Serafini M, Lubsen N, et al.
Cell Stress Chaperones
. 2009 May;
15(1):25-37.
PMID: 19472075
Stress proteins such as heat shock proteins (Hsps) are up-regulated in cells in response to various forms of stress, like thermal and oxidative stress and inflammation. Hsps prevent cellular damage...
3.
Rodriguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D, et al.
Infect Immun
. 2008 Jan;
76(4):1709-18.
PMID: 18212075
Prime-boost vaccination regimens with heterologous antigen delivery systems have indicated that redirection of the immune response is feasible. We showed earlier that T-cell responses to circumsporozoite (CS) protein improved significantly...
4.
Vogels R, Zuijdgeest D, van Meerendonk M, Companjen A, Gillissen G, Sijtsma J, et al.
J Gen Virol
. 2007 Oct;
88(Pt 11):2915-2924.
PMID: 17947512
Replication-incompetent adenovirus type 35 (rAd35) represents a potent vaccine carrier that elicits strong, antigen-specific T- and B-cell responses in diverse preclinical models. Moreover, Ad35 is rare in human populations, resulting...
5.
Ophorst O, Radosevic K, Klap J, Sijtsma J, Gillissen G, Mintardjo R, et al.
Vaccine
. 2007 Jul;
25(35):6501-10.
PMID: 17646036
Previously, we have shown the potency of recombinant Adenovirus serotype 35 viral vaccines (rAd35) to induce strong immune response against the circumsporozoite protein (CS) of the plasmodium parasite. To further...
6.
Ophorst O, Radosevic K, Ouwehand K, van Beem W, Mintardjo R, Sijtsma J, et al.
Vaccine
. 2006 Dec;
25(8):1426-36.
PMID: 17161889
Previous studies have shown that the immunogenicity of rodent malaria parasite-derived circumsporozoite protein (CS) can be improved by deleting the glycosyl-phosphatidyl-inositol (GPI) signal sequence. To study whether GPI signal sequence...